Cyclica (acquired by Recursion, Nasdaq: RXRX)
Biotechnology ResearchOntario, Canada2-10 Employees
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
Recent Acquisition Cyclica's acquisition by Recursion, a publicly traded biotech company, enhances its credibility and market reach, presenting opportunities for collaborative ventures or co-marketing initiatives within the biotech and pharmaceutical sectors.
Growing Platform The launch of Beacons for Brands and an integrated affiliate marketplace indicates an expanding customer base of content creators and brands, offering potential for tailored SaaS solutions, integration partnerships, and add-on services.
Funding & Revenue With a seed funding of 6 million dollars and revenues between 1M and 10M, the company demonstrates growth potential, making it a promising target for strategic investments, technology licensing, or collaborative R&D projects.
Innovative Tech Stack Utilization of advanced tech tools like Profitwell, CDNJS, and PWA suggests a focus on scalable, user-friendly platforms, providing opportunities for partnerships centered around technology integration, enhanced user engagement, and product improvement.
Market Positioning Competing in the emerging creator economy space with competitors like Linkpop, Beacons AI is positioned for growth in digital monetization solutions, presenting opportunities to develop complementary products, integrations, or marketing collaborations aimed at content monetizers and social media influencers.
Cyclica (acquired by Recursion, Nasdaq: RXRX) uses 8 technology products and services including Profitwell, cdnjs, Canny, and more. Explore Cyclica (acquired by Recursion, Nasdaq: RXRX)'s tech stack below.
| Cyclica (acquired by Recursion, Nasdaq: RXRX) Email Formats | Percentage |
| First.Last@cyclicarx.com | 100% |
| First@beacons.ai | 87% |
| Last@beacons.ai | 12% |
| FirstL@beacons.ai | 1% |
Biotechnology ResearchOntario, Canada2-10 Employees
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
Cyclica (acquired by Recursion, Nasdaq: RXRX) has raised a total of $6M of funding over 1 rounds. .
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s revenue is estimated to be in the range of $1M$10M
Cyclica (acquired by Recursion, Nasdaq: RXRX) has raised a total of $6M of funding over 1 rounds. .
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s revenue is estimated to be in the range of $1M$10M